iBio, Inc.
(NYSE Amex Equities : IBIO)

( )
IBIO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
1.01%296.831.4%$601.21m
AMGNAmgen, Inc.
0.32%236.741.3%$499.17m
GILDGilead Sciences, Inc.
-2.75%65.771.0%$359.64m
REGNRegeneron Pharmaceuticals, Inc.
1.15%376.422.6%$305.52m
VRTXVertex Pharmaceuticals, Inc.
-0.71%218.981.9%$273.17m
ILMNIllumina, Inc.
0.85%324.723.5%$237.54m
CLVSClovis Oncology, Inc.
-4.24%12.8614.7%$231.58m
ARWRArrowhead Pharmaceuticals, Inc.
-1.28%66.4611.4%$202.95m
ALXNAlexion Pharmaceuticals, Inc.
-1.82%110.422.0%$199.09m
EXASEXACT Sciences Corp.
2.08%87.2024.0%$164.40m
AAgilent Technologies, Inc.
-1.30%83.711.6%$163.26m
SRPTSarepta Therapeutics, Inc.
31.43%132.0514.6%$153.63m
BLUEbluebird bio, Inc.
6.78%89.7514.2%$146.02m
GBTGlobal Blood Therapeutics, Inc.
-0.01%76.886.0%$140.64m
BOLDAudentes Therapeutics, Inc.
0.05%59.401.4%$134.92m

Company Profile

iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. It operates through the iBio, Inc. and iBio CDMO business segments. The company was founded on April 15, 1993 and is headquartered in New York, NY.